Form D · Biotechnology
Bloonics Holding B.V.
Eindhoven, P7 · CIK 0001787133
Offering snapshot reported May 24, 2023 · SEC filing
- Reported sold
- $125K Offering amount: $275K
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 31, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 24, 2023 | Initial | $125,000 | No comparison | 7 | SEC filing |
| Aug 24, 2021 | Initial | $100,000 | No comparison | Not reported | SEC filing |
| Sep 25, 2019 | Initial | $500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-482492
Simple Agreement for Future Equity (SAFE)
Source: Form D, filed May 24, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alexei L Beresnev | Director |
| Daniel A Cohen | Director |
| Miteshkumar Patel | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Daalakkersweg 6 Unit 12
Eindhoven, P7, 5641 JA
Eindhoven, P7, 5641 JA